Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Article in English | IMSEAR | ID: sea-165006

ABSTRACT

Background: Wound healing is a significant healthcare problem in today’s medical practice. Despite extensive treatment modalities that are supposed to hasten the wound healing process, the outcomes of existing methods are far from optimal. One such agent that has been tried previously and found controversial in wound healing is phenytoin. Therefore, this study was planned to evaluate and compare wound healing effect of topical phenytoin with povidone iodine ointment in rats. Methods: This study was conducted after approval from Institutional Animal Ethics Committee (IAEC). Wound healing activity of topical phenytoin (1 g% and 2 g%) was assessed in excision wound model in Sprague Dawley rats (n=8), which was compared with topical petroleum jelly and povidone iodine ointment. Parameters studied included wound area on day 0, 4, 8, 12, 16, 20, percentage wound contraction, percentage wound healing from day 0 to day 20 and period of re-epithelisation. Results: Wound surface area decreased in all treatment groups from day 0 through day 20 and the percentage wound closure was better in both the preparations (1% and 2%) of phenytoin when compared wih control and povidone iodine, but this was not statistically significant. Furthermore, the days required for complete re-epithelisation were less with phenytoin treated groups. There was no statistical difference between both the preparations of phenytoin. Conclusion: In this study, it was found that topical phenytoin accelerates wound healing process in an excision wound model.

2.
Article in English | IMSEAR | ID: sea-154183

ABSTRACT

Background: Memory is the most common cognitive ability lost with dementia commonly seen in Alzheimer’s disease (AD). Donepezil was the first cholinesterase inhibitor to be licensed in UK for AD. There is preliminary evidence that aspirin decreases the risk and delays the onset of AD. Low dose aspirin users had numerically lower prevalence of Alzheimer’s dementia and had better cognitive function than non-users. Methods: Retention of conditioned avoidance response (CAR) was assessed by using repeated electroconvulsive shocks (ECS) in rats. Rats were divided into five groups: control (pretreated with distilled water), ECS (150 V, 50 Hz, with intensity of 210 mA for 0.5 sec) pretreated, combined aspirin (6.75 mg/kg) and pretreated ECS, combined donepezil (0.32 mg/kg) and pretreated ECS, combined aspirin, donepezil and pretreated ECS groups. Data were analyzed using the Chi-square test and ANOVA. Results: Findings show that administration of ECS daily for 8 days results in transient amnesia and disruption of retention of CAR. Aspirin and donepezil administration significantly increased the retention of CAR in comparison to ECS. However, aspirin failed to show an increase in the retention of CAR as compared to donepezil. The combination of the two drugs showed statistically significant increase in the retention of CAR than either of these drugs given alone. Conclusion: Neuroinflammation plays an important role in the pathophysiology of neurodegenerative disorder like AD. Combination of aspirin with donepezil increased the nootropic and neuroprotective effect of aspirin and thus may hold great clinical significance in such disorders.

SELECTION OF CITATIONS
SEARCH DETAIL